voacamine has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kingston, DG; Prakash Chaturvedula, VS; Schilling, JK; Sprague, S | 1 |
| Condello, M; Gallo, FR; Meschini, S; Multari, G; Pellegrini, E; Vecchiotti, D; Zazzeroni, F | 1 |
2 other study(ies) available for voacamine and Cancer of Ovary
| Article | Year |
|---|---|
New cytotoxic indole alkaloids from Tabernaemontana calcarea from the Madagascar rainforest.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Female; Humans; Indole Alkaloids; Madagascar; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Plants, Medicinal; Tabernaemontana; Tumor Cells, Cultured | 2003 |
A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Ibogaine; Molecular Structure; Ovarian Neoplasms; Paclitaxel | 2022 |